ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
Clinical trial NCT05736874 · COMPLETED
Trial details
- NCT number
- NCT05736874
- Sponsor
- Susanna Naggie, MD
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2022-03-17
- Enrollment
- 1407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.